Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment
المصدر:
Nasdaq GlobeNewswire
/
08 أغسطس 2023 16:05:01 America/New_York
N/A
شارك على،